Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-19
DOI
10.1186/s40425-018-0336-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma
- (2017) Allison S. Betof et al. ONCOLOGIST
- Immunotherapy comes of age: Immune aging & checkpoint inhibitors
- (2017) Rawad Elias et al. Journal of Geriatric Oncology
- Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis
- (2016) Tomohiro F. Nishijima et al. CANCER TREATMENT REVIEWS
- Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
- (2016) Louis Fehrenbacher et al. LANCET
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Checkpoint Inhibitors in Older Adults
- (2016) Rawad Elias et al. Current Oncology Reports
- Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8+T-cell proliferation by distinct pathways
- (2015) Sian M. Henson et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement
- (2015) Arti Hurria et al. JOURNAL OF CLINICAL ONCOLOGY
- The Characterization of Varicella Zoster Virus–Specific T Cells in Skin and Blood during Aging
- (2015) Milica Vukmanovic-Stejic et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunosenescence in the nursing home elderly
- (2014) Jennie Johnstone et al. BMC Geriatrics
- Can exercise-related improvements in immunity influence cancer prevention and prognosis in the elderly?
- (2013) Austin B. Bigley et al. MATURITAS
- Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway
- (2010) Celine S. Lages et al. AGING CELL
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD28− T cells: their role in the age-associated decline of immune function
- (2009) Nan-ping Weng et al. TRENDS IN IMMUNOLOGY
- T cell subset-specific susceptibility to aging
- (2008) Marta Czesnikiewicz-Guzik et al. CLINICAL IMMUNOLOGY
- Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people
- (2008) Sven Koch et al. Immunity & Ageing
- CD95-mediated apoptosis in naïve, central and effector memory subsets of CD4+ and CD8+ T cells in aged humans
- (2007) Sudhir Gupta et al. EXPERIMENTAL GERONTOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started